Deputy Minister of Health of the Republic of Belarus Gennady Godovalnikov told about the situation that prevailed in the pharmaceutical market of Belarus. According to him, Belarusian pharmaceutical market is very different from the markets of CIS countries.The Ministry of Health of the Republic of Belarus created a Department of the development of pharmaceutical industry with the right of a legal entity  in the end of 2011. It administrates the pharmaceutical inspection, quality control, logistics and six pharmaceutical companies of Belarus. Enterprises of Belarus producing about 855 kinds of medicines, only 17 of which are duplicated in several plants,'' said Gennady Godovalnikov. According to him, full GMP have two companies and 15 sites in the other plants. He also noted that the production of 20% of Belarusian medicines is unprofitable, and only 3.37% is the share of Belarusian medicines in the Russian pharmaceutical market. ‘’We have set tough conditions for producers - within 3-4 years they can do packing, after which they must transfer all the names of drugs on the entire production cycle. Packing is a disguised import,'' noted Mr. Godovalnikov. He took the development of 9 new drugs and 65 new substances for the success of the industry. He sais that this allow to say that 50% of medicines in the Republic of Belarus will be the local production by 2012. As for the quality control of drugs, in Belarus has been tested 20,000 batches domestic production of drugs the last year, among which 13 batches were found marriage of the 80,000 foreign parties were rejected 46 drugs parties.

            Director of the Department of State Organization of quality control of drugs of the State Service of Ukraine Sergey Dubovitskiy told about the system of drug control in Ukraine. ‘’For checking the quality of products are responsible 27 territorial offices on three levels: import into the country, admission of business entities, and monitoring the inspectors in carrying out inspections. State Security Service of Ukraine cooperates with the competent authorities within the republic and abroad. In particular, the established cooperation within the CIS, WHO, EMA, and PIC/S.'' The representative of the Ukrainian authorities noted that import of drugs on the territory of Ukraine will be possible only in accordance with the requirements of GMP starting July 1, 2012. In particular, it is one of the measures to protect domestic producers through import substitution in the Ukraine.

            ‘’An agreement on mutual recognition of safety of medicines and registration certificates between countries of the Custom Union has been prepared. Also the plan and terms of design documents in the Custom Union have been approved. According to my data in the discussion of solutions of the Eurasian Economic Commission coordinators of business in different areas are involved,’’ spoke about the work of the Eurasian Economic Commission representative of the Board of Technical Regulation of the Eurasian Economic Commission Simon Perel.

In the final discussion Deputy Director of Development ARPM Asiyat Khubieva summed up the forum and identified the issues that require consideration at the following events.